Stocks Hitting 52-Week Lows

Cell Therapeutics

shares fell 23.58% to touch a new 52-week low of $1.56. Cell Therapeutics priced an underwritten public offering of 60,000 shares of its Series 17 Preferred Stock at a price of $1,000 per share. Cache

shares dropped 20% to create a new 52-week low of $2.60. Cache expects a wider loss for the third quarter. Summer Infant

shares lost 2.34% to create a new 52-week low of $1.67. Summer Infant shares have dropped 74.82% over the past 52 weeks, while the S&P 500 index has gained 26.48% in the same period. O2Micro International Ltd

shares declined 3.11% to create a new 52-week low of $3.43. O2Micro cut its Q3 revenue forecast.